BREAKING House passes Trump's giant tax bill by a single vote Frankfurt - Delayed Quote • EUR Sigma Healthcare Limited (S5YA.F) Follow Add holdings 1.7100 0.0000 (0.00%) As of 8:02:56 AM GMT+2. Market Open. All News Press Releases SEC Filings Sigma Healthcare Full Year 2025 Earnings: AU$0.009 loss per share (vs AU$0.004 profit in FY 2024) Sigma Healthcare ( ASX:SIG ) Full Year 2025 Results Key Financial Results Revenue: AU$4.84b (up 46% from FY 2024). Net... ASX Stocks That Could Be Undervalued In April 2025 In the wake of recent market volatility driven by global tariff tensions, Australian shares are poised for a significant downturn, with ASX 200 futures indicating a sharp decline. Amidst this challenging environment, identifying undervalued stocks requires careful analysis of fundamentals and resilience to external economic pressures. ASX Stocks Estimated To Be Trading At A Discount Of Up To 26.3% The Australian market has been experiencing some turbulence, with tariff uncertainties impacting investor sentiment and resulting in a mixed performance across sectors. Amidst this volatility, identifying undervalued stocks can be an attractive strategy for investors looking to capitalize on potential discounts, particularly when the broader market faces headwinds. Australia's Sigma shareholders approve $5.5 billion Chemist Warehouse merger SYDNEY (Reuters) -Australia's Sigma Healthcare shareholders approved in a vote on Wednesday a merger with Chemist Warehouse to create an A$8.8 billion ($5.50 billion) pharmacy and retailing giant. The decision ends more than a year of deliberations between Sigma, Chemist Warehouse and regulators, which had raised antitrust concerns before giving the green light for the transaction in early November. Sigma will pay the privately held Chemist Warehouse shareholders A$700 million in cash as well as stock to facilitate what would effectively be a backdoor listing of the company on the Australian Securities Exchange (ASX). Ownership Matters in favour of Chemist Warehouse-Sigma Healthcare $5.8 billion deal Sigma Healthcare will conduct a shareholder meeting on Jan. 29 to seek approval for the deal, which will create a $5.8 billion entity. As part of the deal, which was announced in December 2023, Chemist Warehouse will buy Sigma for stock and A$700 million in cash, giving it a roughly 85% stake in the merged entity and a back door to list on the Australian stock exchange. Sigma Healthcare downgraded to Underperform from Hold at Jefferies Jefferies downgraded Sigma Healthcare (SIGGF) to Underperform from Hold with a price target of A$1.85, up from A$1.60. Sigma advised that it expects the proposed merger with Chemist Warehouse implementation to occur in February, notes the firm, which had previously forecast the merger to close at end-December 2024 and cites recent share price appreciation for the firm’s move to Underperform. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Australia clears Chemist Warehouse-Sigma Healthcare $5.8 billion deal The Australian competition regulator, on Thursday, cleared privately owned pharmacy chain Chemist Warehouse's reverse takeover of Sigma Healthcare, paving the way to create an A$8.8 billion ($5.78 billion) entity after a year-long wait. Sigma's stock surged almost 40%, the most on the Australian benchmark index, to hit a record high. Chemist Warehouse had said roughly a year back it would buy Sigma for stock and A$700 million in cash, giving it a roughly 85% stake in the merged entity and a backdoor way to list on the stock exchange at a time when global capital markets were in the doldrums. Australia's Sigma hits 18-yr high on offering concessions for Chemist Warehouse merger (Reuters) -Shares of Sigma Healthcare shot to their highest levels in 18 years on Tuesday, after the Australian healthcare group offered three major concessions to facilitate its A$8.8 billion ($6.09 billion) merger with Chemist Warehouse. Under the proposed concessions, Sigma will let franchisees who joined at the start of 2024 to opt out of their agreements without penalties for the next three years, the Australian Competition and Consumer Commission (ACCC) said in a statement. Additionally, Sigma offered to limit how the company will use confidential information from its wholesale customers and franchisees for the next three years. Sigma Healthcare Ltd (SIGGF) (Q2 2025) Earnings Call Transcript Highlights: Strong Revenue ... Sigma Healthcare Ltd (SIGGF) reports significant revenue growth and strategic advancements despite operational challenges. Unveiling Australia's Hidden Stock Gems For September 2024 Over the last 7 days, the Australian market has risen 2.1%, driven by gains in every sector, and has climbed 13% over the past year. In light of these strong performances and expected annual earnings growth of 12%, identifying stocks with solid fundamentals and growth potential is crucial for capitalizing on this momentum. Performance Overview Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) Return S5YA.F S&P/ASX 200 [XJO] (^AXJO) YTD +8.92% +2.32% 1-Year +130.90% +6.38% 3-Year +466.04% +16.84%